The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Glutaminolysis: A Hallmark of Cancer Metabolism
Open accessAbstract
Glutamine is the most abundant circulating amino acid in blood and muscle and is critical for many fundamental cell functions in cancer cells, including synthesis of metabolites that maintain mitochondrial metabolism; generation of antioxidants to remove reactive oxygen species; synthesis of nonessential amino acids (NEAAs), purines, pyrimidines, and fatty acids for cellular replication; and activation of cell signaling. In light of the pleiotropic role of glutamine in cancer cells, a comprehensive understanding of glutamine metabolism is essential for the development of metabolic therapeutic strategies for targeting cancer cells. In this article, we review oncogene-, tumor suppressor–, and tumor microenvironment–mediated regulation of glutamine metabolism in cancer cells. We describe the mechanism of glutamine's regulation of tumor proliferation, metastasis, and global methylation. Furthermore, we highlight the therapeutic potential of glutamine metabolism and emphasize that clinical application of in vivo assessment of glutamine metabolism is critical for identifying new ways to treat patients through glutamine-based metabolic therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The breakdown of glutamine through glutaminolysis gives rise to glutamate, a critical precursor of most other nonessential amino acids, including aspartate, alanine, arginine, and proline52.”
From The metabolic landscape of RAS-driven cancers from biology to therapy (2021) · cites this paper as [52]
In the citing paper
“Glutamine is also a major source of nitrogen for proliferating cells52,54.”
From The metabolic landscape of RAS-driven cancers from biology to therapy (2021) · cites this paper as [52]
In the citing paper
“In addition to pyruvate-derived acetyl-CoA, α-KG-derived metabolites (e.g., succinate and fumarate) generated via glutaminolysis are considered oncometabolites contributing to tumorigenesis23.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [23]
In the citing paper
“Mitochondrial α-KG can then participate in the TCA cycle, supporting the oxidative phosphorylation (OXPHOS) pathway or the reductive carboxylation pathway23.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 3×
“In order to systematically understand the role of metabolic reprogramming in cancer cells on establishing and maintaining a tumorigenic status, Pavlova & Thompson (2) summarized”
BackgroundAn Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 1×
“As tumors develop, cancer cells recruit nonmalignant stromal cells in their vicinity to form a highly interactive tumor microenvironment (137).”
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
On Respiratory Impairment in Cancer Cells
Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472
Research works printed but not linked: 8
- Smolke CD, 2010, The Metabolic Pathway Engineering Handbook: Fundamentals
- Matsuno T, 1992, Cancer Res, 52, 1192
- 10.1038/nature12040 · DOI · Paper page
- 10.1016/j.cell.2015.07.016 · DOI · Paper page
- Pizer ES, 1996, Cancer Res, 56, 1189
- Levine B, 2015, J. Clin. Investig., 12514
- Majós C, 2004, Am. J. Neuroradiol., 25, 1696
- 10.1158/1535-7163.MCT-13-0870 · DOI · Paper page
Cited by
Sorted by citations
Items 801–860 of 860
Ross, A., Cain, J. W., McLendon, B. A., Kramer, A. C., Bazer, F. W., Wu, G., & Johnson, G. A. (2025) · Biology of Reproduction · doi:10.1093/biolre/ioaf154
Liu, T., Sun, C., Liu, X., Zhao, P., Shao, B., Xu, Y., Xiao, Y., Wang, H., Chen, Q., Yang, G., et al. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1564382 · Cited by 1
Tumor Metabolism: Challenges and Future Perspectives
da Silva, E. L., Montenegro, R. C., & Moreira-Nunes, C. A. (2025) · Springer eBooks · doi:10.1007/978-3-032-00761-2_103
Ulas, O., Yüceer, R. O., Hasbek, Z., Ozer, H., Seker, K., Yılmaz, M., & Uçar, M. (2025) · Medicina · doi:10.3390/medicina61111952
Development of a glutamine-responsive MRI contrast agent
Wilson, C. A., Bruchs, A. T., Fatima, S., Boggs, D. G., Bridwell‐Rabb, J., & Olshansky, L. (2025) · Chemical Science · doi:10.1039/d5sc05987a
Glutamine and allergic rhinitis: A bidirectional two-sample Mendelian randomization study
Fan, S., Guan, Z., Ding, Y., Chen, W., Su, S., Bai, H., & Li, L. (2025) · Medicine · doi:10.1097/md.0000000000045400
Xie, Y., Han, L., Jin, Y., Li, J., Tao, Q., Wu, Y., Liu, Z., Tang, C., He, X., Chen, Y., et al. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000004406
Cao, J., Zhang, X., Xu, P., Wang, H., Wang, S., Zhang, L., Li, Z., Xie, L., Sun, G., Xia, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13520662
Cao, J., Zhang, X., Xu, P., Wang, H., Wang, S., Zhang, L., Li, Z., Xie, L., Sun, G., Xia, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13520659
Cao, J., Zhang, X., Xu, P., Wang, H., Wang, S., Zhang, L., Li, Z., Xie, L., Sun, G., Xia, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13520656
Yang, Y., Wang, Z., Li, X., Lv, J., Zhong, R., Gao, S., Zhang, F., & Chen, W. (2024) · Figshare · doi:10.6084/m9.figshare.26641582
Cao, J., Zhang, X., Xu, P., Wang, H., Wang, S., Zhang, L., Li, Z., Xie, L., Sun, G., Xia, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13520674
Zhu, W., Chang, L., Zhao, T., Wang, B., & Jiang, J. (2020) · Figshare · doi:10.6084/m9.figshare.13071086
Cao, J., Zhang, X., Xu, P., Wang, H., Wang, S., Zhang, L., Li, Z., Xie, L., Sun, G., Xia, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13520665
Cao, J., Zhang, X., Xu, P., Wang, H., Wang, S., Zhang, L., Li, Z., Xie, L., Sun, G., Xia, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13520671
Cao, J., Zhang, X., Xu, P., Wang, H., Wang, S., Zhang, L., Li, Z., Xie, L., Sun, G., Xia, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13520668
Hereditary cancer syndromes linked to oxidative phosphorylation insufficiency
Kaplan, B., Duraj, T., Lee, D. C., & Seyfried, T. N. (2025) · ONCOLOGIE · doi:10.1515/oncologie-2025-0301
Gan, Y., Wei, W., Jiang, B., Zhang, X., Jiang, L., Teng, L., Xie, X., Liu, Y., Xie, Q., & Jiang, L. (2026) · Scientific Reports · doi:10.1038/s41598-025-34313-8
Lysine succinylation: a review of its impacts on the reproductive function and related disease
Huang, X., Huang, Y., Lai, J., Wang, Z., Ge, C., Luo, T., Cui, Y., & li, J. (2026) · Reproduction Fertility and Development · doi:10.1071/rd25115 · Cited by 1
Bykov, Y. S., & Herrmann, J. M. (2026) · Molecular Cell · doi:10.1016/j.molcel.2025.12.014
Li, Y., Li, Z., Liu, X., Qiu, Z., Zhang, R., Li, H., Gao, C., & Guo, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1734414
Wogonin-derived chemotype enables discovery of novel GLS1 inhibitors with potent antitumor activity
Li, X., Liang, Y., Zhang, X., Wu, Y., Wu, T., Tian, Y., Tang, C., Qiu, Z., Wu, H., Bian, J., et al. (2026) · Future Medicinal Chemistry · doi:10.1080/17568919.2026.2642584
Mitochondrial dynamics: A promising tool for personalized TNBC management
Mishra, H., Yadav, A. K., Kushwaha, V. B., & Singh, M. P. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102157 · Cited by 2
Khawkhiaw, K., Lert-itthiporn, W., Seyedasli, N., Chiu, C., & Saengboonmee, C. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.v32.i13.115536
Zhou, Z., Liu, S., Zhang, C., Deng, J., Liang, L., & Zhou, Y. (2026) · Cancer Science · doi:10.1111/cas.70377
Kaminski, L. (2018) · theses.fr (ABES) · doi:10.70675/7f6ae88bz4f3cz49d3zafcdz8682254b2be3
EVT-701 : targeting electron transport chain complex I as therapeutic approach in cancer
Yolba, R. L. (2021) · theses.fr (ABES) · doi:10.70675/9cadea77z03ccz4a54zb381zf34a432615a5
Lai, H.-T., Nguyen, T. N. A., Costa, M. E. M. D., Fernandes, R., Dias‐Pedroso, D., Durand, S., Kroemer, G., Canoy, R. J., Mazzanti, L., Vassetzky, Y. S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.03.716303
Le métabolisme de l'inflammation dans les maladies microcristallines
Pham, C. N. (2024) · theses.fr (ABES) · doi:10.70675/f0753276z83c0z49a8zaacfz19b5d72e5627
Deciphering the metabolic bases of Drosophila intestinal tumors
Delamotte, P. (2024) · theses.fr (ABES) · doi:10.70675/c62595f4zbfe2z4ee5zba1az272c10f57e2a
Gupta, S., Nigam, N., Verma, S. K., Trivedi, R., Venkatesh, V., & Kumar, D. (2026) · ACS Omega · doi:10.1021/acsomega.5c13117
Qu, J., Zhang, X., Jin, Q., Guo, Y., Yu, H., Zhan, G., Mao, W., Xiang, S., Zhao, M., & Jin, H. (2026) · Environment International · doi:10.1016/j.envint.2026.110276
Vaishnavi, M., Kumari, M., Pal, S., Kaur, K., Kaity, S., Mandal, C., & Roy, S. (2026) · In vitro models · doi:10.1007/s44164-026-00119-9
Targeted Metabolic Therapy in Cancer: A Comprehensive Metabolic Treatment Strategy
Anane, Y. (2026) · Cureus · doi:10.7759/cureus.108373
Bespalov, M. M., Gkini, V., İloğlu, Z., Yamada, S., Nemoto, A., Filppu, P., Trontti, K., Andriichuk, L., Pietiläinen, O. P. H., Joncour, V. L., et al. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02318-7
Glutamine Metabolism: Role in Cancer Cell Proliferation and Survival
Chakraborty, A. J., Pramanik, S., Mullick, S., Nath, R., Mondal, M., Pal, R., Ashique, S., & Jana, M. (2026) · Cancer treatment and research · doi:10.1007/978-3-032-21861-2_3
Pham, N. T. K., Trinh, Q. D., Ushijima, H., Komine‐Aizawa, S., & Yoshimune, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114717
Zhang, J., Zhu, Y., Liu, G., Liao, M., Wu, J., Chen, C., Guo, M., Jiang, Y., Zhao, J., & Xu, L. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1806160
Multiomics analyses in young grade C molar incisor pattern periodontitis
Alamri, M. M., Proctor, G., García-Guevara, F., Guennec, A. D. L., Mainas, G., Shoaie, S., & Nibali, L. (2026) · Journal of Dentistry · doi:10.1016/j.jdent.2026.106871
HOTAIR at the metabolic crossroads: lncRNA control of carbohydrate and lipid metabolism
Sánchez-Pérez, J., Trujano-Camacho, S., García-Castillo, V., Olvera-Valencia, M., de León, D. F. C., López–Urrutia, E., & Pérez‐Plasencia, C. (2026) · Epigenomics · doi:10.1080/17501911.2026.2691028
The role of RNA modifications in cancer metabolism
Zhang, J., & Xu, K. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102365
Campos-Sandoval, J. A., Santos-Jiménez, J. D. L., Márquez, J., & Matés, J. M. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18070850
Senlle, S., Nicole, C., Silva, P. M. A., Queirós, O., & Cunha, A. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48070724
Fan, W., Chen, J., Deng, X., Chen, W., Liu, Y., 林其昌, & Lian, N. (2026) · Antioxidants and Redox Signaling · doi:10.1177/15230864261477032
Zhao, L., Yin, Z., Ji, C., Wu, Y., Gao, H., & Yuan, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1911067
The Differences Between Cancer Cells and Normal Cells
Varol, U., & Keskinkılıç, M. (2026) · Springer eBooks · doi:10.1007/978-3-032-23963-1_12
Wu, J., Wang, J., Yu, Z., & Yang, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1856643
Mačvanin, M., Spasic, D. M., Gluščević, S. V., Srdić‐Rajić, T., & Klisic, A. N. (2026) · Archives of Medical Science · doi:10.5114/aoms/225096
Tamura, K., Tsuji, A. B., Nishii, R., Tani, K., Hashimoto, H., 和紀, 河., Zhang, M.-R., Maeda, T., Yamazaki, K., & Higashi, T. (2025) · Institutional Repositories DataBase (IRDB)
Metabolic Analyses of Crosstalk between Pancreatic Stromal and Cancer Cells
Bhinderwala, F., Souchek, J. J., Chaika, N. V., Abdullatif, F., Singh, P. K., Powers, R., & Gebregiworgis, T. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.6c02205
Shao, D., Song, J., & Wang, J. (2026) · Nano Today · doi:10.1016/j.nantod.2026.103188
Wang, S., Fu, Y., & Huang, Y. (2026) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2500179
Glutamine Metabolism in Health and Diseases
Ding, Y., Tong, F., Zeng, J., & Cui, C. (2026) · MedComm · doi:10.1002/mco2.71035
The Glutamine-O-GlcNAc: A central metabolic-signaling crosstalk network in physiology and disease
Shi, R., Zhi, Y., Li, S., Ren, W.-H., Gao, L., & Zhi, K. (2026) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2026.101804
Kumar, H. V. S., Choudhury, D., Lei, P., Mehrotra, P., Shahini, S., Swedick, S., Toftegaard, J., & Andreadis, S. T. (2026) · Aging Cell · doi:10.1111/acel.70703
Xu, R., Zhao, J., Liu, M., Qiao, Y., Ning, X., & Sun, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1939528
Kawase, K. (2026) · Pediatrics International · doi:10.1111/ped.70574
Yuan, X., Wang, Y., Wu, H., Feng, S., Yang, X., Pu, Q., Li, G., Liu, Z., & Zhao, Q. (2026) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2026.119198
Advanced Nanomedicines for Cancer Metabolic Therapy
Duan, Q., Tian, C., Cheng, X., Wang, L., Huo, M., & Shi, J. (2026) · Advanced Materials · doi:10.1002/adma.75365
Zhang, S., Liu, Y., Zhao, H., Chen, H., Li, Y., & Wang, L. (2026) · Journal of Environmental Sciences · doi:10.1016/j.jes.2026.105846
Metadata
- Authors
- Yang, L., Venneti, S., & Nagrath, D.
- Affiliations
- Rice University (US)
- University of Michigan (US)
- Venue
- Annual Review of Biomedical Engineering
- Publisher
- Annual Reviews
- Published
- 2017-06-21
- Volume
- 19
- Issue
- 1
- Pages
- 163-194
- ISSN
- 1523-9829 (ISSN-L)
- 1545-4274
- OpenAlex
- W2534904302
- Cited by
- 859
- References
- 171
- Citations by year
- 2026: 68 · 2025: 140 · 2024: 137 · 2023: 132 · 2022: 126 · 2021: 98 · 2020: 71 · 2019: 46 · 2018: 28 · 2017: 13
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annual Review of Biomedical Engineering (publishedVersion)
- PubMed (publishedVersion)
- Rice Research Repository (Rice University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- glutamine metabolism, glutaminolysis, cancer metabolism, tumor microenvironment, oncogenes, tumor suppressor, metastasis, global DNA methylation, tumor cell proliferation, metabolic therapy, reactive oxygen species, purine and pyrimidine synthesis, signal transduction
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Glutamine, Humans, Mitochondria, Models, Biological, Neoplasms, Biomarkers, Tumor, Signal Transduction, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
